Fig. 2 From: The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertensionClinical algorithms for reaching target blood pressure. ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; CVD, cardiovascular disease; CKD, chronic kidney disease; DM, diabetes mellitus. a)Subclinical organ damage, cardiovascular risk factors ≥3, DM with cardiovascular risk factors ≥1Back to article page